To market Levofloxacin
Zydus Cadila has announced that it has got approval from the United States Food and Drug Administration to market Levofloxacin Injection, 500 mg/20 ml, and 750 mg/30 ml (25 mg/ml), which is used in the treatment of bacterial infections. The product will be produced at the group's formulations manufacturing facility at Moraiya, Ahmedabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
